AustinPx AustinPx (formerly Dispersol Technologies) is a company that focuses on formulation and processing technologies for solubility and bioavailability enhancement of poorly water-soluble drug molecules. | Kamada Pharmaceuticals Kamada Pharmaceuticals is a company that develops plasma-derived protein therapeutics for orphan indications. | Camurus Camurus is a research-based pharmaceutical company that develops medicines for severe and chronic conditions. | |
Founding Date | Founding Date 2007 | Founding Date 1990 | Founding Date 1991 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Georgetown, US HQ | Locations Rehovot, IL HQ Beit Kama, IL | Locations Lund, SE HQ Sydney, AU Mannheim, DE Duxford, GB |
Employees | Employees 412% decrease | Employees 420 | Employees 265 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 317 m | Valuation ($) 3.4 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $180.5m (FY, 2025) | Revenue (est.) kr2.3b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $72.1m (FY, 2025) | Cost of goods kr138.7m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $108.4m (FY, 2025) | Gross profit kr2.1b (FY, 2025) |
Net income | Net income N/A | Net income $20.2m (FY, 2025) | Net income kr735.6m (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 52.7m | Total funding raised $ 90m | Total funding raised N/A |
Kamada Pharmaceuticals is a company that develops plasma-derived protein therapeutics for orphan indications.
View companyCamurus is a research-based pharmaceutical company that develops medicines for severe and chronic conditions.
View company